Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
03 août 2020 08h00 HE
|
Melinta Therapeutics, Inc.
MORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...
Cempra Announces Preliminary Results of 2017 Stockholder Vote
03 nov. 2017 11h59 HE
|
Cempra, Inc.
CHAPEL HILL, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization
01 nov. 2017 07h00 HE
|
Cempra, Inc.; Melinta Therapeutics, Inc.
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company
31 oct. 2017 07h00 HE
|
Cempra, Inc.; Melinta Therapeutics, Inc.
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger
28 sept. 2017 16h15 HE
|
Cempra, Inc.; Melinta Therapeutics
CHAPEL HILL, N.C. and NEW HAVEN, Conn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives...
Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update
07 sept. 2017 16h15 HE
|
Cempra, Inc.
CHAPEL HILL, N.C., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
09 août 2017 08h00 HE
|
Cempra, Inc.; Melinta Therapeutics
—Broad pipeline and resources provide multiple opportunities to drive long-term value creation— —Merger lays strong foundation for launch of recently FDA-approved Baxdela™ (delafloxacin)— ...
Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results
09 août 2017 08h00 HE
|
Cempra, Inc.
CHAPEL HILL, N.C., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Cempra to Report Second Quarter 2017 Financial Results
20 juil. 2017 16h05 HE
|
Cempra, Inc.
CHAPEL HILL, N.C., July 20, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Eight Presentations at ASM Microbe Include Late Breaker From Cempra’s Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
02 juin 2017 07h15 HE
|
Cempra, Inc.
CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...